IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen



Status:Active, not recruiting
Conditions:Prostate Cancer, Cancer, Hematology, Urology
Therapuetic Areas:Hematology, Nephrology / Urology, Oncology
Healthy:No
Age Range:18 - 99
Updated:1/13/2019
Start Date:May 4, 2011
End Date:July 31, 2022

Use our guide to learn which trials are right for you!

A Multicenter, Open-label, Single-arm, Phase 2 Study of Abiraterone Acetate Plus Prednisone in Subjects With Advanced Prostate Cancer Without Radiographic Evidence of Metastatic Disease

The purpose of this study is to show that abiraterone acetate plus prednisone added to the
current standard of care, gonadotropin-releasing hormone (GnRH) decreases prostate specific
antigen (PSA) and prolongs the time until it is evident that the cancer has grown.
Additionally, safety information about abiraterone acetate in combination with prednisone
will be collected. This will include looking at what side effects occur, how often they
occur, and for how long they last.

This is a Phase 2, prospective, multicenter, open-label, single-arm study of abiraterone
acetate plus prednisone in men with non-metastatic, castration-resistant prostate cancer
(CRPC) who have a rising PSA despite castrate levels of testosterone. The study consists of
Screening Phase (up to 4 weeks), Core Study Treatment Phase (comprised of six 28-day cycles),
a Pre-metastatic Disease Follow-up Phase, an Optional Drug Holiday Phase; and a 30-day Safety
Follow-up Visit. Each treatment cycle will last 28 days. Participating participants will
receive study agents (Abiraterone acetate 1000 mg/day plus prednisone 5 mg/day, orally)
continually during the study. If the partcipants elects to participate in the Optional Drug
Holiday Phase, participants will discontinue abiraterone acetate plus prednisone and ADT.
Participants will have the option to return to study medication during the first year of the
Optional Drug Holiday Phase if there is evidence of rising PSA but no metastasis based on
study imaging. If participants do no elect to participate, they will continue with the core
study treatment as per protocol. The study will end when all participated participants have
disease progression or end of the 2-year period (if participants participated in the Optional
Drug Holiday Phase). Participants will be required to return to the study site 30 days after
receiving the last dose of abiraterone acetate for safety follow-up.

Major Inclusion Criteria:

- Be a male >= 18 years of age

- Have adenocarcinoma of the prostate

- Currently receiving continuous treatment with Gonadotropin-releasing hormone (GnRH)
monotherapy for at least 6 months before or have undergone surgical removal of the
testicles

- Serum testosterone of < 50 ng/dL(< 2.0 nM)

- Have rising PSA defined as a PSA of >= 10 ng/mL obtained at screening or PSADT of ≤ 10
months with the first of the 3 consecutive PSA values used to calculate PSADT ≥ 2.0
ng/mL

- Have an Eastern Cooperative Oncology Group (ECOG) performance status less than or
equal to 2

- Be capable of swallowing study agents whole as a tablet

- Be willing/able to adhere to the prohibitions and restrictions specified in this
protocol

Major Exclusion Criteria:

- Have prior or current evidence of local disease progression or metastatic disease as
defined by modified response evaluation criteria in solid tumors (RECIST) criteria

- Have received chemotherapy for treatment of castrate-resistant prostate cancer;
however, if a patient received chemotherapy in an adjuvant setting, prior to having
CRPC, for castrate-sensitive prostate cancer, the patient is still eligible

- Are currently receiving any antiandrogen therapy (eg, bicalutamide, flutamide, or
nilutamide).

- If previously treated with antiandrogen therapy, there must be documentation of at
least 2 consecutive rising PSA values at least 2 weeks apart obtained prior to
screening

- If previously treated with flutamide, at least 1 of the PSA values must be obtained 4
weeks or more after flutamide discontinuation.

- If previously treated with bicalutamide or nilutamide, at least 1 of the PSA values
must be obtained 6 weeks or more after antiandrogen discontinuation

- Have previously received agents having any CYP17 inhibitory activity for the treatment
of prostate cancer, such as ketoconazole

- Have previously received aminoglutethimide

- Have an active infection or other medical condition that would contraindicate
prednisone use

- Have uncontrolled hypertension

- Have active hepatitis or chronic liver disease

- Have clinically significant heart disease

- Have poorly controlled diabetes

- Have received an investigational therapeutic within 30 days of screening

- Have partners of childbearing potential and are not willing to use a method of birth
control with adequate barrier protection as determined to be acceptable by the
principal investigator and sponsor during the study and for 1 week after last dose of
abiraterone acetate.

- Individuals with a history of a non-prostate malignancy are ineligible for this study
with the following exceptions. Individuals with a history of other malignancies are
eligible if they have been disease-free for at least 3 years and are deemed by the
investigator to be at low risk for recurrence of that malignancy. Individuals with the
following cancers are eligible if diagnosed and treated within the past 3 years: basal
cell or squamous cell carcinoma of the skin
We found this trial at
45
sites
2214
mi
from 91732
Raleigh, NC
Click here to add this to my saved trials
2437
mi
from 91732
Albany, NY
Click here to add this to my saved trials
1204
mi
from 91732
Arlington, TX
Click here to add this to my saved trials
1919
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
825
mi
from 91732
Aurora, CO
Click here to add this to my saved trials
2319
mi
from 91732
Aventura, FL
Click here to add this to my saved trials
2301
mi
from 91732
Baltimore, MD
Click here to add this to my saved trials
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
2434
mi
from 91732
Brooklyn, NY
Click here to add this to my saved trials
2180
mi
from 91732
Buffalo, NY
Click here to add this to my saved trials
2194
mi
from 91732
Chapel Hill, NC
Click here to add this to my saved trials
1880
mi
from 91732
Cincinnati, OH
Click here to add this to my saved trials
2032
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
817
mi
from 91732
Denver, CO
Click here to add this to my saved trials
1728
mi
from 91732
Evanston, IL
Click here to add this to my saved trials
1853
mi
from 91732
Fort Wayne, IN
Click here to add this to my saved trials
1579
mi
from 91732
Galesburg, IL
Click here to add this to my saved trials
2452
mi
from 91732
Garden City, NY
Click here to add this to my saved trials
1723
mi
from 91732
Glenview, IL
Click here to add this to my saved trials
Greenville, South Carolina 29605
2019
mi
from 91732
Greenville, SC
Click here to add this to my saved trials
1786
mi
from 91732
Homewood, AL
Click here to add this to my saved trials
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
1785
mi
from 91732
Huntsville, AL
Click here to add this to my saved trials
1814
mi
from 91732
Jeffersonville, IN
Click here to add this to my saved trials
2313
mi
from 91732
Lancaster, PA
Click here to add this to my saved trials
1894
mi
from 91732
Lansing, MI
Click here to add this to my saved trials
LawrenceVille, New Jersey 08648
2396
mi
from 91732
LawrenceVille, NJ
Click here to add this to my saved trials
13
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
1718
mi
from 91732
Melrose Park, IL
Click here to add this to my saved trials
1722
mi
from 91732
Milwaukee, WI
Click here to add this to my saved trials
Myrtle Beach, South Carolina 29572
2234
mi
from 91732
Myrtle Beach, SC
Click here to add this to my saved trials
1763
mi
from 91732
Nashville, TN
Click here to add this to my saved trials
1655
mi
from 91732
New Orleans, LA
Click here to add this to my saved trials
2435
mi
from 91732
New York, NY
Click here to add this to my saved trials
1300
mi
from 91732
Omaha, NE
Click here to add this to my saved trials
2179
mi
from 91732
Orange City, FL
Click here to add this to my saved trials
2375
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
2119
mi
from 91732
Pittsburgh, PA
Click here to add this to my saved trials
2433
mi
from 91732
Poughkeepsie, NY
Click here to add this to my saved trials
2275
mi
from 91732
Rockville, MD
Click here to add this to my saved trials
105
mi
from 91732
San Diego, CA
Click here to add this to my saved trials
355
mi
from 91732
San Francisco, CA
Click here to add this to my saved trials
964
mi
from 91732
Seattle, WA
Click here to add this to my saved trials
2428
mi
from 91732
Staten Island, NY
Click here to add this to my saved trials
427
mi
from 91732
Tucson, AZ
Click here to add this to my saved trials